期刊文献+

血UA水平与急性脑梗死患者颈动脉斑块及梗死分型的关系 被引量:2

Relation of Blood Uric Acid Levels with Cerebral Infarction and Plaque Type of Acute Cerebral Infarction Patients
原文传递
导出
摘要 目的:探讨血尿酸(UA)水平与急性脑梗死(ACI)患者颈动脉斑块及梗死分型的关系。方法:选择2013年11月~2016年5月本院收治的ACI患者200例,依据牛津郡社区卒中研究分型(OCSP)标准将患者分为完全前循环梗死(TACI)组,部分前循环梗死(PACI)组、后循环梗死(POCI)组和腔隙性梗死(LACI)组;依据斑块性质将所有患者分为无斑块组、稳定斑块组和不稳定斑块组,分析不同梗死分型和斑块性质患者血UA水平差异。结果:TACI组与PACI组、POCI组与LACI组组间UA水平比较差异无统计学意义(P>0.05),而TACI组和PACI组均高于POCI组和LACI组,差异有统计学意义(P<0.05);UA水平与OCSP分型存在相关性(r=0.237,P=0.001);无斑块组UA水平与稳定斑块组的差异无统计学意义(P>0.05);不稳定斑块组UA水平显著高于无斑块组和稳定斑块组,差异有统计学意义(P<0.05),UA水平与不同斑块性质分型存在相关性(r=0.356,P=0.000);ACI患者总体OCSP分型和斑块性质存在相关性(r=0.334,P=0.000)。结论:血UA水平与ACI患者颈动脉斑块及梗死分型存在相关性,应重视ACI患者UA水平的检测,以预防脑梗死。 Objective: To explore the relation of blood uric acid levels with cerebral infarction and plaque type of acute cerebral infarction(ACI) patients. Methods: 200 ACI patients admitted to our hospital from November 2012 to May 2016 were selected, All patients were divided into total anterior circulation infarction group(TACI), partial anterior circulation infarction(PACI) group, posterior circulation infarction(POCI) group and lacunar infarction(LACI) group according to Oxfordshire community stroke project(OCSP) classification criteria;And all patients were divided into no plaque group, stable plague group and unstable plaque group according to plaque type, the relation of blood uric acid levels with cerebral infarction and plaque type were analyzed. Results: The difference of UA level between TACI group and PACI group, POCI group and LACI group were both not statistically significant(P〈0.05). The UA level of TACI group and PACI group were higher than those of POCI group and LACI group(P〉0.05). UA levels and OCSP classification of ACI patients was correlated(r=0.237, P=0.001). The difference of UA level between no plaque group and stable plaque group was not statistically significant(P〉0.05).UA level of unstable plaque group was significantly higher than those in no plaque group and stable plague group,the difference was statistically significant(P〈0.05). Plaque type and OCSP classification was correlated(r=0.356, P=0.000). OCSP classification and plaque type were correlated(r=0.334, P=0.000). Conclusion: Blood UA levels and cerebral infarction and plaque type of ACI patients were correlated,attentions should be paid to UA levels of ACI patients to preventive cerebral infarction.
出处 《现代生物医学进展》 CAS 2017年第5期940-942,981,共4页 Progress in Modern Biomedicine
关键词 急性脑梗死 血尿酸 脑梗死分型 颈动脉斑块 Acute cerebral infarction Uric acid Infarction classification Carotid artery plaque
作者简介 王鹏(1982-),男,本科,主治医师,从事神经临床医学方面的研究,E-mail:wangpeng20217@sinacom
  • 相关文献

参考文献2

二级参考文献39

  • 1沈丽华,柯开富,顾晓苏,吴二兵,陈翔.脑梗死与颈动脉斑块及血脂的相关性分析[J].南通大学学报(医学版),2008,28(4):279-280. 被引量:10
  • 2周雪珍.颈动脉斑块和狭窄与急性脑梗死的相关分析[J].临床和实验医学杂志,2007,6(3):54-54. 被引量:18
  • 3Shinichi Takayama,Takaaki Sato,Stanislaw Krajewski,Kristine Kochel,Shinji Irie,Juan A Milian,John C Reed.Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity[J]. Cell . 1995 (2)
  • 4Hiroshi Kusunoki,Yoshiaki Taniyama,Junya Azuma,Kazuma Iekushi,Fumihiro Sanada,Rei Otsu,Masaaki Iwabayashi,Keita Okayama,Hiromi Rakugi,Ryuichi Morishita.Telmisartan Exerts Renoprotective Actions via Peroxisome Proliferator-Activated Receptor-γ/Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1 Receptor Blockade[J]. Hypertension . 2012 (2)
  • 5Keita Okayama,Junya Azuma,Norio Dosaka,Kazuma Iekushi,Fumihiro Sanada,Hiroshi Kusunoki,Masaaki Iwabayashi,Hiromi Rakugi,Yoshiaki Taniyama,Ryuichi Morishita.Hepatocyte Growth Factor Reduces Cardiac Fibrosis by Inhibiting Endothelial-Mesenchymal Transition[J]. Hypertension . 2012 (5)
  • 6Kazuma Iekushi,Yoshiaki Taniyama,Hiroshi Kusunoki,Junya Azuma,Fumihiro Sanada,Keita Okayama,Nobutaka Koibuchi,Masaaki Iwabayashi,Hiromi Rakugi,Ryuichi Morishita.Hepatocyte Growth Factor Attenuates Transforming Growth Factor-β-Angiotensin II Crosstalk Through Inhibition of the PTEN/Akt Pathway[J]. Hypertension . 2011 (2)
  • 7Diler Aslan.Biomarkers for Diabetes Complications: The Results of Several Clinical Studies[J]. Journal of Medical Biochemistry . 2011 (3)
  • 8Kazuma Iekushi,Yoshiaki Taniyama,Junya Azuma,Fumihiro Sanada,Hiroshi Kusunoki,Toyohiko Yokoi,Nobutaka Koibuchi,Keita Okayama,Hiromi Rakugi,Ryuichi Morishita.Hepatocyte growth factor attenuates renal fibrosis through TGF-β1 suppression by apoptosis of myofibroblasts[J]. Journal of Hypertension . 2010 (12)
  • 9Hironori Nakagami,Mariana Kiomy Osako,Futoshi Nakagami,Takashi Shimosato,Noriko Minobe,Toshinori Moritani,Munehisa Shimamura,Takashi Miyake,Hideo Shimizu,Yasushi Takeya,Ryuichi Morishita.Prevention and regression of non-alcoholic steatohepatitis (NASH) ina rat model by metabosartan, telmisartan[J]. International Journal of Molecular Medicine . 2010 (4)
  • 10Swapnil N. Rajpathak,Tao Wang,Sylvia Wassertheil-Smoller,Howard D. Strickler,Robert C. Kaplan,Aileen P. McGinn,Rachel P. Wildman,Daniel Rosenbaum,Thomas E. Rohan,Philipp E. Scherer,Mary Cushman,Gloria Y.F. Ho.Hepatocyte Growth Factor and the Risk of Ischemic Stroke Developing Among Postmenopausal Women: Results From the Women?s Health Initiative[J]. Stroke . 2010 (5)

共引文献8

同被引文献41

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部